SUGAR LAND--April 17, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--When June 2014 draws to a close, the Pharmaceutical-Biotech Industry is forecast to have launched nearly $9 billion worth of North American capital and maintenance projects during the previous three months. The stunning number reflects a 91% increase over last year's figures.
Other companies featured: Emergent Biosolutions (NYSE:EBS), Endo Pharmaceuticals (NASDAQ:ENDP)
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×